BILLEV PHARMA ApS — Credit Rating and Financial Key Figures

BILLEV PHARMA ApS (CVR number: 81814813) is a company from HØRSHOLM. The company recorded a gross profit of 24.8 mDKK in 2023. The operating profit was 4356.7 kDKK, while net earnings were 3378.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 55.3 %, which can be considered excellent and Return on Equity (ROE) was 75.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 53.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. BILLEV PHARMA ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.